Masimo Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Masimo Corporation sits in the top decile of US sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count).
Masimo Corporation: 96 sponsored US clinical trials, 3 recruiting.
Masimo Corporation sponsors 96 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 80 completed. The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
Masimo Corporation ranks in the top decile of sponsors by registered trial count (#245 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
80 of 93 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
96 total, page 2 of 2
Oxygen Reserve Index (ORi) Validation of INVSENSOR00014
NCT03500341
Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study
NCT03482505
INVSENSOR00013 Respiratory Rate Clinical Performance Study
NCT03440619
Desaturation Validation of INVSENSOR00006
NCT03435211
Desaturation Validation of INVSENSOR00012
NCT03435224
Desaturation Validation of INVSENSOR00009
NCT03396835
Comparison of Rainbow INVSENSOR00001 and Control SpHb Disposable Sensor Performance During Hemodilution
NCT03273166
MightySat - Clinical Performance Comparison Study
NCT03239574
Validation of Noninvasive Hemoglobin, Comparison of PVI to Standard Methods, and Validation of Clinical Efficacy of ORI
NCT02841397
SpO2 Validation of Noninvasive Red Diamond Disposable Pulse Oximeter Sensor
NCT03124602
Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection
NCT03121144
Accuracy of Oxygen Saturation (SpO2) Noninvasive Pulse Oximeter Sensor (RD Disposable) Under Motion Conditions
NCT03124784
SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation
NCT03128931
Plethysmographic and Acoustic Respiration Rate Clinical Data Collection
NCT03038074
EEG Data Collection to Evaluate New Patient State Index Performance
NCT02954952
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
NCT03128853
Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients
NCT03021551
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
NCT02930850
Evaluation of Non-Invasive Hemoglobin in Trauma Patients
NCT03123328
Oxygen Reserve Index Validation for RD Lite Sensors
NCT03128892
Rainbow Acoustic Monitoring (RAM) Clinical Engineering Data Collection
NCT03120897
Spot-Check Noninvasive Pulse CO-Oximeter Validation
NCT02782806
Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (RD DCI)
NCT03124797
Correlation Endoscopic View of Airway Obstruction With RRa in OSA Patients Under DEX Monitored With SedLine EEG
NCT02639884
Accuracy of Noninvasive Pulse Oximeter Sensor (Rainbow DCI)
NCT03124823
Calibration and Validation of Masimo's O3 Regional Oximetry Device in Neonates, Infants and Children
NCT03123354
Performance Equivalence of Rainbow Acoustic Monitoring (RAM) Small Sensor and RAM Revision D Sensor
NCT03122405
Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)
NCT03125135
Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX)
NCT03125018
Comparison of Noninvasive Hemoglobin Disposable Sensors
NCT03125031
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
NCT03120702
Pulse CO-Oximetry Noninvasive Monitoring and Laboratory Measurements of Subject Blood Samples
NCT01638455
Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor
NCT03125005
Accuracy of Noninvasive Pulse Oximeter Sensor (LNCS DBI)
NCT03124979
Accuracy of Noninvasive Hemoglobin Pulse Oximeter (Rainbow Resposable Adhesive Sensors)
NCT03124771
Use of Rainbow Acoustic Monitoring in Pediatric Patients - A Clinical Engineering Data Collection Protocol
NCT03128827
Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)
NCT03124758
Accuracy of Hemoglobin Measurement for Various Rainbow Pulse Oximeter Sensors
NCT03124966
Accuracy of Methemoglobin Measurement of Various Rainbow Pulse Oximeter Sensors
NCT03124836
Rainbow DCI vs. R1-25 Sensor SpHb Sub-Range Performance Equivalence
NCT03157232
Rainbow R2-25 vs. R1-25 SpHb Sub-Range Performance Equivalence
NCT03134326
Accuracy of Acoustic Rainbow Monitoring (ARM) Sensor
NCT03124862
Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor
NCT03134313
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
NCT03124901
Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor
NCT03124693
Accuracy of Methemoglobin Measurement for Rainbow DCI Sensors
NCT03124927
Therapeutic Areas
What is open in the Masimo Corporation pipeline
3 recruiting of 96 indexed (3% open); 80 completed (83%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Healthy (12 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Masimo Corporation: open-pipeline peers nationwide
Peers matched on 96 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
Masimo Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 96 trials (± recruiting share)
- University of Mississippi Medical Center · 96 trials · 10% recruiting
- University of Tennessee · 96 trials · 13% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- AdventHealth · 95 trials · 17% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Allina Health System · 3% recruiting · 32 trials
- CooperVision · 3% recruiting · 64 trials
- MiMedx Group · 3% recruiting · 32 trials
- Sharp HealthCare · 3% recruiting · 32 trials
Related
What to do with this Masimo Corporation page
96 registered trials is a research-attention snapshot, not an endorsement of Masimo Corporation or any single study.
- 3 of Masimo Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition Masimo Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Masimo Corporation pipeline card: 96 registered trials from official public datasets.Report a data error.